LONDON May 6 AstraZeneca Plc said it
would step up its interactions with shareholders this week,
following Pfizer Inc's $106 billion takeover approach,
which the British drugmaker has dismissed as inadequate.
Chief Executive Pascal Soriot told reporters on Tuesday
there was a range of opinion among the group's investors over
the Pfizer approach but the overall feedback had been supportive
of AstraZeneca's decision to reject the bid.
AstraZeneca laid out its defence against Pfizer's earlier on
Tuesday by predicting its revenues would rise sharply over the
next 10 years as promising new drugs in its pipeline kicked in.
(Reporting by Ben Hirschler; editing by Tom Bergin)